The number of people with susceptibility test result for rifampicin in Armenia

Armenia: The number of people with susceptibility test result for rifampicin was 209 in 2021. ▼ Falling

Latest (2021)
209
Change on year
up 5.6%
World rank
93rd
of 155 countries
All-time high
320
in 2017
All-time low
198
in 2020
Years of data
5
2017–2021

The number of people with susceptibility test result for rifampicin in Armenia, 2017–2021

01002003002017201920212017: 3202018: 2502019: 2332020: 1982021: 209

Source: World Health Organization, Global Health Observatory.

Analysis

The most recent figure for the number of people with susceptibility test result for rifampicin in Armenia is 209, measured in 2021.

That represents a change of up 5.6% on the previous year and down 34.7% over five years.

Armenia ranks 93rd of 155 countries on this measure, in the middle of the range.

The number of people with susceptibility test result for rifampicin in Armenia, year by year

Annual values for The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients. in Armenia, 2017 to 2021.
Year Value Change
2017 320
2018 250 -21.9%
2019 233 -6.8%
2020 198 -15.0%
2021 209 +5.6%

Armenia compared with similar countries

  • Armenia's 209 is below the median for upper middle income countries, which is 880, 24% of the median. (46 countries reporting)
  • Armenia's 209 is below the median for Europe & Central Asia, which is 229.5, 91% of the median. (44 countries reporting)

Averages by decade

DecadeAverage LowestHighest Years
2010s 267.67 233 320 3
2020s 203.5 198 209 2

Countries ranked near Armenia

  1. 90 Czechia 239 compare
  2. 91 Lebanon 228 compare
  3. 92 Switzerland 220 compare
  4. 94 Venezuela, Bolivarian Republic of 198 compare
  5. 95 Macau, China 193 compare
  6. 96 Kiribati 177 compare

See the full ranking of 157 places →

More health data for Armenia

All data for Armenia →

Frequently asked questions

What is the number of people with susceptibility test result for rifampicin in Armenia?
The number of people with susceptibility test result for rifampicin in Armenia was 209 in 2021, according to World Health Organization, Global Health Observatory.
What is the highest the number of people with susceptibility test result for rifampicin recorded in Armenia?
The highest recorded value was 320 in 2017.
What is the lowest the number of people with susceptibility test result for rifampicin recorded in Armenia?
The lowest recorded value was 198 in 2020.
How does Armenia rank for the number of people with susceptibility test result for rifampicin?
Armenia ranks 93rd out of 155 countries with data for 2021.
Where does this Armenia data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

The number of people with susceptibility test result for rifampicin in Armenia. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 16 September 2026, from https://health.statizoid.com/stat/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among/armenia/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among/armenia/">The number of people with susceptibility test result for rifampicin in Armenia</a> — Statizoid

About this data

Indicator
The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
157 places, 785 data points, 2017–2021
Last refreshed